Combination treatment selection methods and systems
원문보기
IPC분류정보
국가/구분
United States(US) Patent
등록
국제특허분류(IPC7판)
G06F-017/30
G06F-019/00
출원번호
US-0387961
(2009-05-08)
등록번호
US-9239906
(2016-01-19)
발명자
/ 주소
Hyde, Roderick A.
Ishikawa, Muriel Y.
Leuthardt, Eric C.
Levien, Royce A.
Lord, Robert W.
Malamud, Mark A.
Sweeney, Elizabeth A.
Wood, Jr., Lowell L.
Wood, Victoria Y. H.
출원인 / 주소
The Invention Science Fund I, LLC
인용정보
피인용 횟수 :
0인용 특허 :
100
초록▼
Methods, computer program products, and systems are described that include accepting at least one attribute of at least one individual, querying at least one database at least partly based on the at least one attribute, selecting from the at least one database at least one bioactive agent and at lea
Methods, computer program products, and systems are described that include accepting at least one attribute of at least one individual, querying at least one database at least partly based on the at least one attribute, selecting from the at least one database at least one bioactive agent and at least one artificial sensory experience to address the at least one attribute of at least one individual, and/or presenting an indication of the at least one bioactive agent and the at least one artificial sensory experience at least partly based on the selecting from the at least one database at least one bioactive agent and at least one artificial sensory experience to address the at least one attribute of at least one individual.
대표청구항▼
1. A system including hardware comprising: circuitry configured for accepting at least one mental attribute of at least one individual based at least partly on monitored usage of at least one mobile device by the at least one individual;circuitry configured for querying at least one database at leas
1. A system including hardware comprising: circuitry configured for accepting at least one mental attribute of at least one individual based at least partly on monitored usage of at least one mobile device by the at least one individual;circuitry configured for querying at least one database at least partly based on the at least one mental attribute;circuitry configured for selecting from the at least one database at least one artificial sensory experience for use in combination with at least one bioactive agent to address the at least one mental attribute of the at least one individual; andcircuitry configured for implementing the at least one artificial sensory experience using at least one graphical user interface of the at least one mobile device at least partly based on selection from the at least one database of the at least one artificial sensory experience to address the at least one mental attribute of the at least one individual. 2. The system of claim 1, wherein the circuitry configured for accepting at least one mental attribute of at least one individual based at least partly on monitored usage of at least one mobile device by the at least one individual comprises: circuitry configured for accepting at least one stress attribute of at least one individual based at least partly on monitored usage of at least one mobile device by the at least one individual. 3. The system of claim 1, wherein the circuitry configured for accepting at least one mental attribute of at least one individual based at least partly on monitored usage of at least one mobile device by the at least one individual comprises: circuitry configured for accepting at least one memory attribute of at least one individual based at least partly on monitored usage of at least one mobile device by the at least one individual. 4. The system of claim 1, wherein the circuitry configured for accepting at least one mental attribute of at least one individual based at least partly on monitored usage of at least one mobile device by the at least one individual comprises: circuitry configured for accepting at least one mental impairment of at least one individual based at least partly on monitored usage of at least one mobile device by the at least one individual. 5. The system of claim 1, wherein the circuitry configured for selecting from the at least one database at least one artificial sensory experience for use in combination with at least one bioactive agent to address the at least one mental attribute of the at least one individual comprises: circuitry configured for selecting from the at least one database at least one artificial sensory experience for use in combination with at least one memory-dampening agent to address the at least one mental attribute of the at least one individual. 6. The system of claim 1, wherein the circuitry configured for selecting from the at least one database at least one artificial sensory experience for use in combination with at least one bioactive agent to address the at least one mental attribute of the at least one individual comprises: circuitry configured for selecting from the at least one database at least one virtual experience for use in combination with at least one bioactive agent to address the at least one mental attribute of the at least one individual. 7. The system of claim 1, wherein the circuitry configured for selecting from the at least one database at least one artificial sensory experience for use in combination with at least one bioactive agent to address the at least one mental attribute of the at least one individual comprises: circuitry configured for selecting from the at least one database at least one of the following types of artificial sensory experiences for use in combination with at least one bioactive agent to address the at least one mental attribute of the at least one individual: an artificial memory scene, a visual narrative, a virtual world, a social networking website, an online game, an online educational experience, a networked game, or a single-player game. 8. The system of claim 1, wherein the circuitry configured for selecting from the at least one database at least one artificial sensory experience for use in combination with at least one bioactive agent to address the at least one mental attribute of the at least one individual comprises: circuitry configured for selecting from the at least one database at least one artificial sensory experience, based on a treatment algorithm, for use in combination with at least one bioactive agent to address the at least one mental attribute of the at least one individual. 9. The system of claim 1, wherein the circuitry configured for implementing the at least one artificial sensory experience using at least one graphical user interface of the at least one mobile device at least partly based on selection from the at least one database of the at least one artificial sensory experience to address the at least one mental attribute of the at least one individual comprises: circuitry configured for implementing the at least one artificial sensory experience using at least one graphical user interface of the at least one mobile device at a staggered time relative to administration of the at least one bioactive agent, at least partly based on selection from the at least one database of the at least one artificial sensory experience to address the at least one mental attribute of the at least one individual. 10. The system of claim 1, wherein the circuitry configured for accepting at least one mental attribute of at least one individual based at least partly on monitored usage of at least one mobile device by the at least one individual comprises: circuitry configured for accepting at least one indication of anxiety of at least one individual based at least partly on monitored usage of at least one mobile device by the at least one individual. 11. The system of claim 1, wherein the circuitry configured for implementing the at least one artificial sensory experience using at least one graphical user interface of the at least one mobile device at least partly based on selection from the at least one database of the at least one artificial sensory experience to address the at least one mental attribute of the at least one individual comprises: circuitry configured for implementing the at least one artificial sensory experience including at least modifying one or more user interfaces of at least one application on the at least one mobile device at least partly based on selection from the at least one database of the at least one artificial sensory experience to address the at least one mental attribute of the at least one individual. 12. The system of claim 1, further comprising: circuitry configured for monitoring one or more interpersonal interactions using the at least one mobile device of the at least one individual. 13. The system of claim 12, wherein the circuitry configured for accepting at least one mental attribute of at least one individual based at least partly on monitored usage of at least one mobile device by the at least one individual comprises: circuitry configured for accepting at least one indication of depression of the at least one individual based at least partly on one or more monitored interpersonal interactions using the at least one mobile device of the at least one individual. 14. The system of claim 13, wherein the circuitry configured for selecting from the at least one database at least one artificial sensory experience for use in combination with at least one bioactive agent to address the at least one mental attribute of the at least one individual comprises: circuitry configured for selecting from the at least one database, based at least partly on geographic information associated with the at least one individual, at least one artificial sensory experience for use in combination with at least one anti-depressant agent to address the at least one indication of depression of the at least one individual. 15. The system of claim 14, wherein the circuitry configured for implementing the at least one artificial sensory experience using at least one graphical user interface of the at least one mobile device at least partly based on selection from the at least one database of the at least one artificial sensory experience to address the at least one mental attribute of the at least one individual comprises: circuitry configured for implementing the at least one artificial sensory experience using at least one graphical user interface of the at least one mobile phone device at one or more staggered times relative to administration of the at least one anti-depressant agent based at least partly on one or more pharmacokinetic profiles of the at least one anti-depressant agent, at least partly based on selection from the at least one database of the at least one artificial sensory experience to address the at least one indication of depression of the at least one individual. 16. The system of claim 1, wherein the circuitry configured for accepting at least one mental attribute of at least one individual based at least partly on monitored usage of at least one mobile device by the at least one individual comprises: circuitry configured for accepting at least one indication of anxiety of at least one individual based at least partly on monitored usage of at least one mobile device by the at least one individual,wherein the circuitry configured for selecting from the at least one database at least one artificial sensory experience for use in combination with at least one bioactive agent to address the at least one mental attribute of the at least one individual includes, but is not limited to, circuitry configured for selecting from the at least one database at least one virtual experience for use in combination with at least one anxiolytic agent to address the at least one indication of anxiety of the at least one individual, andwherein the circuitry configured for implementing the at least one artificial sensory experience using at least one graphical user interface of the at least one mobile device at least partly based on selection from the at least one database of the at least one artificial sensory experience to address the at least one mental attribute of the at least one individual includes, but is not limited to, circuitry configured for implementing the at least one virtual experience using at least one graphical user interface of the at least one mobile device to address the at least one indication of anxiety of the at least one individual. 17. The system of claim 1, wherein the circuitry configured for accepting at least one mental attribute of at least one individual based at least partly on monitored usage of at least one mobile device by the at least one individual comprises: circuitry configured for accepting at least one indication of at least one mood disorder of at least one individual based at least partly on monitored usage of at least one mobile device by the at least one individual,wherein the circuitry configured for selecting from the at least one database at least one artificial sensory experience for use in combination with at least one bioactive agent to address the at least one mental attribute of the at least one individual includes, but is not limited to, circuitry configured for selecting from the at least one database at least one user interface modification for use in combination with at least one mood stabilizer agent to address the at least one mood disorder of the at least one individual,wherein the circuitry configured for implementing the at least one artificial sensory experience using at least one graphical user interface of the at least one mobile device at least partly based on selection from the at least one database of the at least one artificial sensory experience to address the at least one mental attribute of the at least one individual includes, but is not limited to, circuitry configured for implementing the at least one user interface modification using at least one graphical user interface of the at least one mobile device to address the at least one mood disorder of the at least one individual. 18. The system of claim 1, wherein the circuitry configured for accepting at least one mental attribute of at least one individual based at least partly on monitored usage of at least one mobile device by the at least one individual comprises: circuitry configured for accepting at least one indication of at least one psychotic disorder of at least one individual based at least partly on monitored usage of at least one mobile device by the at least one individual,wherein the circuitry configured for selecting from the at least one database at least one artificial sensory experience for use in combination with at least one bioactive agent to address the at least one mental attribute of the at least one individual includes, but is not limited to, circuitry configured for selecting from the at least one database at least one visual experience for use in combination with at least one antipsychotic agent to address the at least one psychotic disorder of the at least one individual, andwherein the circuitry configured for implementing the at least one artificial sensory experience using at least one graphical user interface of the at least one mobile device at least partly based on selection from the at least one database of the at least one artificial sensory experience to address the at least one mental attribute of the at least one individual includes, but is not limited to, circuitry configured for implementing the at least one visual experience using at least one graphical user interface of the at least one mobile device to address the at least one psychotic disorder of the at least one individual. 19. The system of claim 1, further comprising: circuitry configured for accepting at least one indication of appearance of the at least one individual; andcircuitry configured for accepting at least one indication of body movement associated with the at least one individual,wherein the circuitry configured for accepting at least one mental attribute of at least one individual based at least partly on monitored usage of at least one mobile device by the at least one individual includes, but is not limited to, circuitry configured for accepting at least one indication of depression of at least one individual based at least partly on monitored usage of at least one mobile device by the at least one individual, at least one indication of appearance of the at least one individual, and the at least one indication of body movement of the individual. 20. The system of claim 1, wherein the circuitry configured for accepting at least one mental attribute of at least one individual based at least partly on monitored usage of at least one mobile device by the at least one individual comprises: circuitry configured for accepting at least one memory attribute of at least one individual based at least partly on one or more audio recordings associated with usage of at least one mobile device by the at least one individual,wherein the circuitry configured for selecting from the at least one database at least one artificial sensory experience for use in combination with at least one bioactive agent to address the at least one mental attribute of the at least one individual includes, but is not limited to, circuitry configured for selecting from the at least one database at least one virtual world experience usable to elicit at least one memory in the at least one individual and usable in combination with at least one memory-dampening agent to address the at least one memory attribute of the at least one individual, andwherein the circuitry configured for implementing the at least one artificial sensory experience using at least one graphical user interface of the at least one mobile device at least partly based on selection from the at least one database of the at least one artificial sensory experience to address the at least one mental attribute of the at least one individual includes, but is not limited to, circuitry configured for implementing the at least one virtual world experience using at least one graphical user interface of the at least one mobile device to elicit the at least one memory in the at least one individual at one or more specified times relative to administration of the at least one memory-dampening agent. 21. The system of claim 1, wherein the circuitry configured for accepting at least one mental attribute of at least one individual based at least partly on monitored usage of at least one mobile device by the at least one individual comprises: circuitry configured for detecting at least one mental attribute of at least one individual based at least partly on monitored usage of at least one mobile device by the at least one individual. 22. The system of claim 1, further comprising: circuitry configured for administering the at least one bioactive agent at one or more staggered times relative to implementation of the at least one artificial sensory experience based at least partly on one or more specified effects of the at least one bioactive agent to address the at least one mental attribute of the at least one individual. 23. A system comprising: means for accepting at least one mental attribute of at least one individual based at least partly on monitored usage of at least one mobile device by the at least one individual;means for querying at least one database at least partly based on the at least one mental attribute;means for selecting from the at least one database at least one artificial sensory experience for use in combination with at least one bioactive agent to address the at least one mental attribute of the at least one individual; andmeans for implementing the at least one artificial sensory experience using at least one graphical user interface of the at least one mobile device at least partly based on selection from the at least one database of the at least one artificial sensory experience to address the at least one mental attribute of the at least one individual. 24. A method implemented using one or more computer processing components, the method comprising: accepting at least one mental attribute of at least one individual based at least partly on monitored usage of at least one mobile device by the at least one individual;querying at least one database at least partly based on the at least one mental attribute;selecting from the at least one database at least one artificial sensory experience for use in combination with at least one bioactive agent to address the at least one mental attribute of the at least one individual; andimplementing the at least one artificial sensory experience using at least one graphical user interface of the at least one mobile device at least partly based on selection from the at least one database of the at least one artificial sensory experience to address the at least one mental attribute of the at least one individual. 25. A system comprising: at least one memory comprising one or more executable instructions;at least one processor operably connected to the at least one memory, wherein the at least one processor is configured to execute the one or more executable instructions to effectuate operations including at least:accepting at least one mental attribute of at least one individual based at least partly on monitored usage of at least one mobile device by the at least one individual;querying at least one database at least partly based on the at least one mental attribute;selecting from the at least one database at least one artificial sensory experience for use in combination with at least one bioactive agent to address the at least one mental attribute of the at least one individual; andimplementing the at least one artificial sensory experience using at least one graphical user interface of the at least one mobile device at least partly based on selection from the at least one database of the at least one artificial sensory experience to address the at least one mental attribute of the at least one individual. 26. A system comprising: a mobile phone device; andone or more non-transitory storage media bearing one or more instructions that when executed on the mobile phone device cause the mobile phone device to perform operations including at least: accepting at least one mental attribute of at least one individual based at least partly on monitored usage of the mobile phone device by the at least one individual; querying at least one database at least partly based on the at least one mental attribute; selecting from the at least one database at least one artificial sensory experience for use in combination with at least one bioactive agent to address the at least one mental attribute of the at least one individual; and implementing the at least one artificial sensory experience using at least one graphical user interface of the at least one mobile phone device at least partly based on selection from the at least one database of the at least one artificial sensory experience to address the at least one mental attribute of the at least one individual.
연구과제 타임라인
LOADING...
LOADING...
LOADING...
LOADING...
LOADING...
이 특허에 인용된 특허 (100)
McCullough, Thomas J., Analytical tool for managing the treatment of chronic illnesses.
Hyde, Roderick A.; Ishikawa, Muriel Y.; Leuthardt, Eric C.; Levien, Royce A.; Lord, Robert W.; Malamud, Mark A.; Sweeney, Elizabeth A.; Wood, Jr., Lowell L.; Wood, Victoria Y. H., Combination treatment alteration methods and systems.
Hyde, Roderick A.; Ishikawa, Muriel Y.; Leuthardt, Eric C.; Levien, Royce A.; Lord, Robert W.; Sweeney, Elizabeth A.; Malamud, Mark A.; Wood, Jr., Lowell L.; Wood, Victoria Y. H., Combination treatment alteration methods and systems.
Hyde, Roderick A.; Ishikawa, Muriel Y.; Leuthhardt, Eric C.; Levien, Royce A.; Lord, Robert W.; Malamud, Mark A.; Sweeney, Elizabeth A.; Wood, Jr., Lowell L.; Wood, Victoria Y. H., Combination treatment modification methods and systems.
Birkner, Charles Christian; ElDahdah, Elias George; Kirkland, Heather Ann; Martinez, David Frederick, Computerized laboratory information management system.
Oshlack Benjamin (New York NY) Chasin Mark (Manalpan NJ) Minogue John J. (Mount Vernon NY) Kaiko Robert F. (Weston CT), Controlled release oxycodone compositions.
Suffin,Stephen C.; Emory,W. Hamlin; Brandt,Leonard J., Electroencephalography based systems and methods for selecting therapies and predicting outcomes.
Kehr Bruce A. (9429 Holbrook La. Potomac MD 20854) Lerner David (New York NY) Demenus Richard D. (New York NY) Edl Michael J. (New York NY), Electronic medication dispensing method.
Gerald E. Goetz ; Terry Precht ; Eric Krug ; Andrew Fanton ; Joe Keating ; Brian Coppom ; Bradley Thompson ; Brian Hepp, Medication monitoring system and apparatus.
Geerts, Hugo; Spiros, Athan, Method and apparatus for computer modeling of the interaction between and among cortical and subcortical areas in the human brain for the purpose of predicting the effect of drugs in psychiatric and cognitive diseases.
Christopher J. Frederickson ; Donald J. Hayes ; David B. Wallace ; David W. Taylor ; Matthew D. Hayes, Method and apparatus for delivery of fragrances and vapors to the nose.
Miller Steven L. ; Merzenich Michael M. ; Peterson Bret E., Method and apparatus for dynamically tailoring biochemical based therapy programs in human.
Webster Henry L. ; Barlow Wayne K. ; Briscoe Dennis R. ; Quirante Carmelo G. ; Thomas Scot B., Method and system for continuous sweat collection and analysis.
Hyde, Roderick A.; Ishikawa, Muriel Y.; Leuthardt, Eric C.; Levien, Royce A.; Lord, Robert W.; Malamud, Mark A.; Sweeney, Elizabeth A.; Wood, Jr., Lowell L.; Wood, Victoria Y. H., Methods and systems for detecting a bioactive agent effect.
Hyde, Roderick A.; Ishikawa, Muriel Y.; Leuthardt, Eric C.; Levien, Royce A.; Lord, Robert W.; Malamud, Mark A.; Sweeney, Elizabeth A.; Wood, Jr., Lowell L.; Wood, Victoria Y. H., Methods and systems for monitoring bioactive agent use.
Hyde, Roderick A.; Ishikawa, Muriel Y.; Leuthardt, Eric C.; Levien, Royce A.; Lord, Robert W.; Malamud, Mark A.; Sweeney, Elizabeth A.; Wood, Jr., Lowell L.; Wood, Victoria Y. H., Methods and systems for presenting a combination treatment.
Hyde, Roderick A.; Ishikawa, Muriel Y.; Leuthardt, Eric C.; Levien, Royce A.; Lord, Robert W.; Malamud, Mark A.; Sweeney, Elizabeth A.; Wood, Jr., Lowell L.; Wood, Victoria Y. H., Methods and systems for presenting a combination treatment.
Leamon, John H.; McDade, Keith E.; Fierro, Joseph M.; Knight, James R.; Charumilind, Jaran; Myers, Jr., Eugene W.; Simpson, John W.; Volkmer, Greg A., Methods of amplifying and sequencing nucleic acids.
Lloyd Harry A. (11101 Sweetwood La. Oakton VA 22124) Jones Timothy (17 Court St. P.O. Box 160 Windsor VA 23487) Dunn Dan C. (23 Hearthstone Rd. Monroe CT 06468), Portable electronic medication dosage instruction and alarm device.
Thrall Karla D. (3804 Alder Lake Ct. West Richland WA 99353) Kenny Donald V. (6947 Sparrow La. Worthington OH 43235) Endres George W. R. (2112 Briarwood Ct. Richland WA 99352) Sisk Daniel R. (1211 Ma, Real time chemical exposure and risk monitor.
Agrafiotis Dimitris K. (Exton PA) Bone Roger F. (Bridgewater NJ) Salemme Francis R. (Kennett Square PA) Soll Richard M. (Lawrenceville NJ), System and method of automatically generating chemical compounds with desired properties.
Patton David L. ; Fredlund John R. ; Horwitz Cecelia M. ; Mir Jose M., System and method of managing a psychological state of an individual using images.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.